These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2307 related articles for article (PubMed ID: 20574901)

  • 1. Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.
    Zhang Q; Bhattacharya S; Andersen ME; Conolly RB
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):253-76. PubMed ID: 20574901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual tissues in toxicology.
    Shah I; Wambaugh J
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):314-28. PubMed ID: 20574905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity testing in the 21st century: bringing the vision to life.
    Andersen ME; Krewski D
    Toxicol Sci; 2009 Feb; 107(2):324-30. PubMed ID: 19074763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of toxicity testing.
    Andersen ME; Al-Zoughool M; Croteau M; Westphal M; Krewski D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):163-96. PubMed ID: 20574896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity testing in the 21st century: how will it affect risk assessment?
    Rhomberg LR
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):361-75. PubMed ID: 20574908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The U.S. Environmental Protection Agency strategic plan for evaluating the toxicity of chemicals.
    Firestone M; Kavlock R; Zenick H; Kramer M;
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):139-62. PubMed ID: 20574895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SysBioMed report: advancing systems biology for medical applications.
    Wolkenhauer O; Fell D; De Meyts P; Blüthgen N; Herzel H; Le Novère N; Höfer T; Schürrle K; van Leeuwen I
    IET Syst Biol; 2009 May; 3(3):131-6. PubMed ID: 19449974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward computational systems biology.
    You L
    Cell Biochem Biophys; 2004; 40(2):167-84. PubMed ID: 15054221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing exposure characterization for chemical evaluation and risk assessment.
    Cohen Hubal EA; Richard A; Aylward L; Edwards S; Gallagher J; Goldsmith MR; Isukapalli S; Tornero-Velez R; Weber E; Kavlock R
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):299-313. PubMed ID: 20574904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity testing in the 21st century: implications for human health risk assessment.
    Krewski D; Andersen ME; Mantus E; Zeise L
    Risk Anal; 2009 Apr; 29(4):474-9. PubMed ID: 19144067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein biomarkers for in vitro testing of toxicology.
    Schrattenholz A; Šoškić V; Schöpf R; Poznanović S; Klemm-Manns M; Groebe K
    Mutat Res; 2012 Aug; 746(2):113-23. PubMed ID: 22405942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic modeling and analysis of cancer cellular network motifs.
    Cloutier M; Wang E
    Integr Biol (Camb); 2011 Jul; 3(7):724-32. PubMed ID: 21674097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing the National Academy's Vision and Strategy for Toxicity Testing: opportunities and challenges under the U.S. Toxic Substances Control Act.
    Locke PA; Bruce Myers D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):376-84. PubMed ID: 20574909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems biology and addiction.
    Tretter F; Gebicke-Haerter PJ; Albus M; an der Heiden U; Schwegler H
    Pharmacopsychiatry; 2009 May; 42 Suppl 1():S11-31. PubMed ID: 19434548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologically relevant exposure science for 21st century toxicity testing.
    Hubal EA
    Toxicol Sci; 2009 Oct; 111(2):226-32. PubMed ID: 19602574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynamic paradigm in psychopathology: "chaos theory", from physics to psychiatry].
    Pezard L; Nandrino JL
    Encephale; 2001; 27(3):260-8. PubMed ID: 11488256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure science and the U.S. EPA National Center for Computational Toxicology.
    Cohen Hubal EA; Richard AM; Shah I; Gallagher J; Kavlock R; Blancato J; Edwards SW
    J Expo Sci Environ Epidemiol; 2010 May; 20(3):231-6. PubMed ID: 18985077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 116.